HighTower Advisors LLC Acquires New Position in The Beauty Health Company (NASDAQ:SKIN)

HighTower Advisors LLC bought a new position in The Beauty Health Company (NASDAQ:SKIN) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 84,800 shares of the company’s stock, valued at approximately $121,000. HighTower Advisors LLC owned approximately 0.07% of Beauty Health at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Cohen Capital Management Inc. boosted its stake in shares of Beauty Health by 344.1% in the 3rd quarter. Cohen Capital Management Inc. now owns 572,848 shares of the company’s stock valued at $825,000 after purchasing an additional 443,859 shares in the last quarter. Federated Hermes Inc. lifted its stake in Beauty Health by 349,616.0% in the second quarter. Federated Hermes Inc. now owns 370,699 shares of the company’s stock worth $712,000 after purchasing an additional 370,593 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in Beauty Health by 24.9% in the second quarter. Bank of New York Mellon Corp now owns 348,108 shares of the company’s stock worth $668,000 after purchasing an additional 69,329 shares during the last quarter. FMR LLC boosted its position in Beauty Health by 0.3% during the third quarter. FMR LLC now owns 18,603,037 shares of the company’s stock valued at $26,788,000 after buying an additional 58,826 shares during the period. Finally, Susquehanna Fundamental Investments LLC bought a new position in shares of Beauty Health during the second quarter valued at about $105,000. 93.26% of the stock is currently owned by institutional investors.

Beauty Health Price Performance

Shares of Beauty Health stock opened at $1.57 on Friday. The company’s fifty day simple moving average is $1.57 and its two-hundred day simple moving average is $1.64. The Beauty Health Company has a 12-month low of $0.91 and a 12-month high of $5.17. The firm has a market cap of $194.87 million, a PE ratio of -3.74 and a beta of 0.85. The company has a quick ratio of 5.57, a current ratio of 6.56 and a debt-to-equity ratio of 9.23.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group boosted their target price on Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a research note on Wednesday, November 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $2.55.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.